The Polypeptide Structure of Immunoglobulin: Experimental Studies on the Recombination of Radiolabelled Myeloma Polypeptide Chains by WETTER, O.
388 Wetter: The polypeptidc structure of immunoglobulin
Z. Klin. Chetn. Klin. Biochem.
11. Jg. 1973, S. 388—392
The Polypeptide Structure of Immunoglobulin:
Experimental Studies on the Recombination of Radiolabelled
Myeloma Polypeptide Chains1)
By O. WETTER
Innere Klinik und Poliklinik (Tumorforschung) (Direktor: Prof. Dr. C. G. Schmidt) der Gesamthochschule Essen
(Eingegangen am 10. Mai 1973)
Experiments using polypeptide chains of immunoglobulins2) have been performed by several authors to study the requirements of the
formation of Ig molecules in vitro from the constituent H- and L-chains3). Where interest was focussed on chemical problems, myeloma
proteins were used, owing to their ready accessibility in pure form and in sufficient quantity.
For the experiments described in this text chromatographically isolated IgG myeloma proteins were used. The percentage of recombined
polypeptides was evaluated from the sedimentation pattern and from the starch gel electrophoresis of isolated H- and L-chains. In the
experiments with Η-chains in the form of an exclusively fast sedimenting fraction (9.5 S), the percentage of recombined molecules was
significantly smaller than in experiments using Η-chains in a non-aggregated form (4.6 S). The influence of the ratio of H:L chains in the
recombination mixture was also studied and in accordance with other authors a proportion of 3:1 was found to be most favorable with
respect to the maximum regain of y-globulin molecules.
ber Untersuchungen zum Studium des Rekombinationsverhaltens der H- und L-Polypeptidketten3) von Immunglobulinen2) ist verschie-
dentlich berichtet worden. Myelom-Proteine sind f r diese Studien insbesondere dann verwendet worden, wenn die physiko-chemischen
Bedingungen 2ur Rekombination interessierten. Die m helose Gewinnung relativ gro er Substanzmengen in reiner Form aus dem Blut
von Myelom-Patienten bietet g nstige Voraussetzungen f r derartige Versuche in vitro.
F r die in der vorliegenden Arbeit dargestellten Untersuchungen wurden chrom tographisch isolierte IgG-Paraproteine benutzt. Das
Rekombinations-Ergebnis wurde unter Heranziehung des Ergebnisses der Sedimentationsanalyse in der Ultrazentrifuge und der St rkegel-
Elektrophorese beurteilt. In den Experimenten mit H-Polypeptidketten, die ausschlie lich eine schrell sedimentierende Komponente von
9,5 S auf wiesen, war der Prozentsatz rekombinierter Molek le deutlich geringer als in Versuchen mit Η-Ketten in nicht-aggregierter Form
(4,6 S). Es wurde weiterhin der Einflu des Verh ltnisses von H-rL^Kette auf das Rekombinations-Ergebnis untersucht. In berein-
stimmung mit anderen Autoren wurde ein H:L-Verh ltnis von 3:1 als optimal f r die Rekonstit tion von 7S-y-Globulin-Molek len
gefunden.
Polypeptide chains obtained by the reduction of myeloma nation conditions with respect to the quantitative regain
proteins show a strong tendency to recombine to a cer- of 7S-molecules, using 125I- and 131I-labelled myeloma
tain extent, even in heterologous mixtures, i. e., in proteins,
mixtures of heavy (H-) and light (L-) chains from diffe-
rent myeloma proteins. This "unspecifity" of reconstitu- Materials and Methods
tion of y-globulin molecules has also been observed in
 The myeloma proteins He. and Sch. were isolated from the serum
mixtures of H- and L-chains of y-globulins of different of two myeloma patients He. and Sch. In order to avoid alteration
species (1). On the other hand, the specific recombi- of the Proteins as far as possible, chromatography on DEAE-
nation of autologous myeloma polypeptide chains has SePhadex A~50 were employed for the preparation. As lyophi'liza-
ι , ι , ρ · ι ι · i · · *ί°η is often accompanied by a reduction of solubility the bulk ofbeen demonstrated by preferential binding experiments
 myeloma protein Jd for fu*ther treatment was used ^ ecdy from
(2) and optical rotatory dispersion measurements (3, 4). the column eluate. Only the small portion for iodination was
With respect to the considerable differences in hetero- lyophilized.
logous recombination experiments with myeloma poly- Reductive cleavage and alkylation of the proteins was performed
peptide chains found by other authors (2) and in own acc<*din^to F^ISCHMAN et al (6). Separation of myeloma poly.Γ Γ
 ;
 /rx . ι . ·, , peptide chains was performed by gel filtration on Sephadex G-75
experiments (5) two points have to be considered:
 in t mol/1 propionic acid.
1. a possible effect of the preparative procedures on the For the urea starch ?el electrophoresis of reduced myeloma pro-
reactivity of H- and L-polypeptide chains, tdns the Procedure &™ b? SMITHIES (7) was followed Sedimen-
0 , . c ι Λ r τ τ ι τ Λ . tation analyses were done m the standard cell at 59780 rpm and
2. the existence of structural features of H- and L-chains
 a phase-plate angle of 60° in the analytical Spinco ultracentrifuge
which might be related to antigenic properties of these Model E.
chains and which might favour the formation of certain Immunelectrophoresis was done according to SCHEIDEGGER (8).
H/L-chain constellation during the recombination Antiscra from Behring-Werke/Marburg were used:
experiments. i) This work was supported by Deutsche Forschungsgemeinschaft,
The experiments described in the following have been *)\\&teviated\e
performed with the intention of studying the recombi- 3)
 H and L froin heavy resp. light.
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lodination of myeloma proteins He. and Sch. was performed
according to McCoNAHEY and DIXON (9). Naml and Naml were
obtained from Fa. Hoechst/Frankfurt4). The specific activity was
100—200 Ci/mg protein. An automatic liquid scintillation counter
(Fa. Telefunken/Siemens) was used. 5 mg of the iodinated material
were mixed with about 300 mg of the myeloma protein before
reduction by mercaptoethanol.
For recombination, H- and L-chains isolated by gel filtration in
1 mol/1 propionic acid were mixed in the ratios (H: L), 3:1,4:1 and
2:1 and dialyzed against 0.15 mol/1 SORENSEN phosphate buffer,
pH 5.O.
The concentration of the fractions from gel filtration after re-
combination were calculated from their specific radioactivity.
Results
IgG myeloma protein He. and Sch. were isolated in an
electrophoretically and immunoelectrophoretically pure
form. Both proteins are of L-chains type κ and belong
to Η-chain subgroup Gx5).
The elution diagram of the reduced and alkylated pro-
tein He. on Sephadex G-75 showed 3 peaks (fig. 1).
Immunoelectrophoretially material from fraction I and
fraction II was identified by an anti-y-chain anriserum;
material from peak III was precipitated by an anti-κ-
antiserum. Reduced and alkylated protein Sch. was
eluted in 2 fractions (fig. 2). Fraction I did not form
a precipitation line in the immunoelectrophoresis,
fraction II was identified by an anti-x-antiserum.
The result of urea starch gel electrophoresis of these
fractions is shown in figure 3. It may be seen that
fraction I of protein He. reveals three bands, fraction II
one strong component followed by a weak component
and fraction III one band well in front of the fractions I
andll.
Fractions I and II of the reduced myeloma protein Sch.
were homogeneous, while fraction II again travelled well
in front of fraction I. Sedimentation coefficients of
fraction I, fraction Π and fraction ΠΙ-protein He. and
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Fig. 1
Elution diagram of reduced alkylated m I -labelled myeloma protein
He. on Sephadex G-75 in 1 mol/I propionic acid
4) For the labelling of the proteins I am obliged to Dr. H. E. REIS,
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Fig. 2
Elution diagram of reduced alkylated '"(-labelled myeloma protein
Sch. on Sephadex G-75 in 1 mol/1 propionic acid
8
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Fig. 3
Starch gel electrophoresis of fraction I (1), fraction II (3) of the reduced
alkylated "Ί-labelled myeloma protein Sch. (2) and of fraction I (7),
fraction II (6), fraction I I I (4) of the reduced alkylated lail-labelled
myeloma protein He. (5)
Tab. 1
Sedimentation coefficients of H- and L-polypeptide chains of myeloma
proteins He. and Sch. in 0.15 mol/1 phosphate buffer (SORENSEN) pH 5.0
Myeloma protein Sample Sedimentation coefficients
(Svedberg units)
He.
He.
He.
Sch.
Sch.
H1
H*
L
H
L
3.5
3.1
4.8
4.6
7.7
9.6
9.5
5) We thank Dr. TiscHENDORF/Tubingen for the typing of H-chain
subgroup.
fraction I and fraction II-protein Sch. are summarized
in table 1. The result of gel filtration of a mixture of
131I-labelled Η-chains He. of fraction I6) (fig. 1) and
125I-labelled L-chains Sch. is shown by figure 4. 79.3%
of 125I-kbelled L-chains Sch. appear together with H-
chains He. at tube No. 27/28. The result of gel filtration
of the mixture of Η-chains He. of fraction II (fig. 1)
and L-chains Sch. is shown in figure 5.
92.9% of the 125I-activity was diverted from the second
peak (tube No. 42/43) to the first peak (tube No. 28/29).
The result of gel filtration of a mixture of 125I-labelled
Η-chains Sch. and 131I-labelled L-chains He. is depicted
in figure 6. 56% of L-chains were found under the first
6) These Η-chains are designated H1, the Η-chains of fr. II (fig. 1)
are designated H2.
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Fig. 4
Elution diagram of a mixture of 131I-iabelIed »»-chains He. (O) and
of I25l-labelled L-chains Sen. (^) at the ratio 3:1 on a mass basis.
Sephadex 0-200 in 0.15 mol/l SORENSEN buffer, ρ Η 5.0. Extent of
recombination 91.6%
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Fig. 6
Elution diagram of a mixture of "«I-labelled Η-chains Sen. (+>) and
ml-labelled L-chairis He. (O) at the ratio 3: 1 on a mass basis. Sepha-
dex G-200 in'0.15 mol/I SORENSEN buffer pH 5.O. Extent of recombi-
nation 55.5%
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Fig. 7
Elution diagram of a mixture of 125I-labeIIed L-chains Sen. (A.) and
"^-labelled L-chaines He. (O) at the ratio 1:1. Sephadex G-200 in
0.15 mol/l S0RENSEN buffer pH 5.0
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Elution diagram of a mixture Of iall-labelled H2-chains He. iri a poly-
meric state (O) and 128I-labelled L-chains Sen. (A) at the ratio 3: 1
on a mass basis. Sephadex G-200 in 0.15 mol/l S0RENSEN buffer ρ Η 5.0.
Extent of recombination 79.3 %
Tab. 2
Percentage of iodinated L-chains diverted from their original position
in the G-200 elution diagram after mixing with H-chains
Mixture of chains
H/L
He'./Sch.
Hea./Sch.
Sch./He.
Sch./He.
Sch./He.
Ratio of chains L-chain diversion
H:L _. %
3:
3:
3:
4:
2:
79.3
92.9
55.5 °
41.6
33.9
Fig. 8
Sedimentation analyses of H^-polypeptide chains (H*) of myeloma
protein He. (a), L-chains of myeloma protein Sen. (b) and of a 3: 1
mixture of these polypeptides (c) in 0.15 mol/l SORENSEN phosphate
buffer, ρ Η 5.0. (For details see text.) Direction .of sedimentation pro-
cess from the left to the right; protein concentration (g/I): 2.8 (a), 1.2(b), 1.6 (c). Fotograph 9 min., 24 min. and 27 min. after reaching full
speed.
peak (tube No. 22). The result of ttje gel filtration
experiments are summarized in table 2.
L-chains He. and Sch. did not interact under these con-
ditions (fig. 7).
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Fig. 9
Immunoelectrophoresis of Η-chains He. (a), L-chains Sch. (b) recom-
bined protein (c, d). Antisera: a — anti-y-chain, b — anti-K-chain,
c = anti-IgG, d = anti-human; sample in the upper part, normal
serum in the lower part of each plate. y-Chain marked by the [arrow.
The sedimentation analyses of the material resulting
from recombination of Η-chains He2, and L-chains Sch.
(He2./Sch.) showed a single component of 6.4S. In
figure 8 the result of sedimentation analyses of H-chains
(He2.) and L-chains Sch. and of a mixture of these chains
at the ratio of 3:1 are shown. The result of the immuno-
electrophoresis is shown in figure 9.
Discussion
Whereas the elution diagram of the reduced and alky-
lated protein Sch. shows two peaks, that of protein He.
reveals three components. By starch gel electrophoresis,
it could be demonstrated that the two incompletely
resolved peaks consist of Η-chains probably in some
polymeric state. No L-chains could be detected in these
components by immunoelectrophoresis.
Aggregation of Η-chains in buffers at neutral pH is one
of the main obstacles in recombination experiments.
Satisfactory results have been obtained by the use of
a three step dialysis procedure (2). Recently a single-
solvent recombination procedure has been described,
which takes advantage of the use of 0.004 mol/1 sodium
acetate buffer at pH 5.4 (10). In this solvent H-chains
of human IgG and myeloma protein were found to be
stable up to three weeks in the cold as monodisperse
dimers. In these experiments the proteins were prepared
by precipitation with 1.6 mol/1 (NH4)2SO4 or by the
method of COHN (fraction II 1—2).
The myeloma proteins used in our experiments were
isolated chromatographically and mixed with the small
amount of material, which was lyophilized prior to
iodination. In earlier recombination experiments (11)
under the same conditions with lyophilized myeloma
proteins, the yield of recombined polypeptides was about
40%; this effect of lyophilization must be taken into con-
sideration. Moreover it is remarkable, that very fast
sedimenting components of ~ 15S, as they had been
observed with lyophilized proteins (12) did not appear
with non-lyophilized proteins. As an aggregation of
Η-chains to 17S components can be achieved by adding
sodium chloride to a final concentration of 0.1 mol/1 to
y-chains in a 0.004 mol/1 sodium acetate buffer (10), the
tendency to aggregate seems to depend more on the
nature or the state of the protein than on the ionic
strength of the buffer. Otherwise one would expect the
formation of the fast sedimenting components in the
0.15 mol/1 SORENSEN phosphate buffer of nearly the same
pH. This is neither the case in Η-chains prepared shortly
after the reduction of the myeloma proteins, nor in pre-
parations stored for 3 weeks in the cold.
Most probably the high recombination rate of ~ 80 or
90% is the consequence of this situation.
The sedimentation coefficients of the H1- and H2-chain
peak from gel filtration show predominantly a 4.8S and
a 4.6S component, respectively, which most probably
consist of dimers of Η-chains. The ^-fraction may con-
tain some material faster than 7.7S, which could not be
measured, because of low concentration, but which
might cause the elution profile (tab. 1).
The absence of a 4.6S or 4.8S component, i. e., H-chain
dimers, in the Η-chain material Sch. may explain the
better recombination rate in the experiment He./Sch. in
comparison with the experiment Sch./He. A comparable
regain of 7S-molecules has been observed by the above-
mentioned authors (10) using L-chains in an excess to
Η-chains. As the results show, no L-chain exess is needed
under the experimental conditions described here.
The antigenic behavior of the 6.4S components, which
resulted from recombination of H- and L-chains is that of
an IgG molecule (fig. 9).
The stability of these molecules should be based ex-
clusively on non-covalent forces. This can be concluded
from the result of a gel filtration experiment with a
mixture of 126I-labelled L-chains Sch. and 131I-labelled
L-chains He (fig. 7). No interaction can be detected as
far as the formation of material is concerned, which is
of the size of the y-globulin molecule. This indicates that
no reactive sulfhydryl groups remained after alkylation.
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